Advanced Oncotherapy Plc announced that Lord David Evans has stepped down from the Board with immediate effect. In addition, the board of directors of the company intends to appoint Professor Stephen Myers as member of the Board. Professor Steve Myers OBE, was appointed Executive Chairman of ADAM S.A. a year ago and, since then, has delivered with the ADAM team significant progress in designing and developing the company's next-generation proton beam cancer therapy technology, the ground-breaking LIGHT system. Professor Myers was Head of Medical Applications at CERN in Geneva from 2014 until 2016. From 2009-2013, he was the Director of Accelerators and Technology, where he was responsible for the operation and exploitation of the whole CERN accelerator complex, with particular emphasis on the Large Hadron Collider and for the development of the new projects and technologies.